Was Neha Narkhede’s Confluent (CFLT) share sale under a 10b5-1 plan?

Yes. The filing notes the 80,000 Class A shares were sold under a Rule 10b5-1 trading plan adopted on June 10, 2025. Such plans pre-schedule trades, helping insiders diversify holdings while following regulatory and corporate governance guidelines.

Confluent director exercises options, sells 80K Class A

Confluent, Inc. director Neha Narkhede reported a combination of option exercises, share conversions, and an open-market sale.

Filing Impact

(Very High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Confluent, Inc. director Neha Narkhede reported a combination of option exercises, share conversions, and an open-market sale. She exercised stock options for 80,000 shares, which led to the conversion of 80,000 shares of Class B Common Stock into 80,000 shares of Class A Common Stock. She then sold 80,000 Class A shares at a price of $30.59 per share pursuant to a pre-established Rule 10b5-1 trading plan adopted on June 10, 2025. After these transactions, she held 28,549 shares of Class A Common Stock directly and 1,787 shares of Class A Common Stock indirectly through a trust, while retaining a substantial Class B stake and remaining option holdings.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Narkhede Neha

Role Director

Sold 80,000 shs ($2.45M)

Approx. gross sale proceeds $2.45M

Approx. exercise cost $179K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	80,000	$0.00	$0.00
Exercise	Class B Common Stock	80,000	$0.00	$0.00
Conversion	Class B Common Stock	80,000	$0.00	$0.00
Conversion	Class A Common Stock	80,000	$0.00	$0.00
Sale	Class A Common Stock	80,000	$30.59	$2.45M
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 377,502 contracts (Direct); Class B Common Stock — 1,083,729 contracts (Direct); Class A Common Stock — 28,549 shares (Direct); Class A Common Stock — 1,787 shares (Indirect, By Trust)

Footnotes (4)

F1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
F2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.
F3. The shares were sold at prices ranging from $30.53 to $30.64. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4. Fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Confluent (CFLT) director Neha Narkhede report in this Form 4?

Neha Narkhede reported exercising options for 80,000 shares, converting Class B into Class A stock, and selling 80,000 Class A shares. These transactions reflect routine equity compensation activity combined with a planned share sale disclosed in detail, including pricing and remaining ownership.

How many Confluent (CFLT) shares did Neha Narkhede sell and at what price?

She sold 80,000 shares of Confluent Class A Common Stock at $30.59 per share. A footnote adds that sale prices ranged from $30.53 to $30.64, with full trade breakdowns available on request from the reporting person to interested parties.

What are Neha Narkhede’s Confluent (CFLT) holdings after these transactions?

After the reported trades, she held 28,549 shares of Class A Common Stock directly and 1,787 Class A shares indirectly through a trust. The filing also shows remaining Class B Common Stock and vested stock options, indicating a continued significant equity interest.

What derivative transactions did Neha Narkhede report for Confluent (CFLT)?

She reported exercising a stock option for 80,000 shares and converting 80,000 Class B Common Stock into Class A Common Stock. These derivative transactions were recorded at a $0.00 exercise price and increased her Class A holdings before the subsequent open-market sale.

How many Confluent (CFLT) shares did Neha Narkhede retain in options after exercising?

Following the option exercise, the filing lists 377,502 stock options remaining. These options are described as fully vested in a footnote, indicating they are currently exercisable according to the terms of the company’s equity compensation arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/18/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Narkhede Neha

(Last)

(First)

(Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW

94041

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	02/13/2026		C		80,000	A	⁽¹⁾	108,549	D
Class A Common Stock	02/13/2026		S		80,000⁽²⁾	D	$30.59⁽³⁾	28,549	D
Class A Common Stock								1,787	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$2.24	02/13/2026		M			80,000	⁽⁴⁾	10/21/2028	Class B Common Stock	80,000	$0	377,502	D
Class B Common Stock	⁽¹⁾	02/13/2026		M		80,000		⁽¹⁾	⁽¹⁾	Class A Common Stock	80,000	$0	1,163,729	D
Class B Common Stock	⁽¹⁾	02/13/2026		C			80,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	80,000	$0	1,083,729	D

Explanation of Responses:

1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.

3. The shares were sold at prices ranging from $30.53 to $30.64. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Fully vested.

	/s/ Weilyn Wood, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR